15961435

Source:http://linkedlifedata.com/resource/pubmed/id/15961435

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016360, umls-concept:C0030705, umls-concept:C0144576, umls-concept:C0205179, umls-concept:C0205390, umls-concept:C0220825, umls-concept:C0278502, umls-concept:C0332174, umls-concept:C0332283, umls-concept:C0549178, umls-concept:C0574032
pubmed:issue	6
pubmed:dateCreated	2005-6-29
pubmed:abstractText	We conducted a phase I trial of escalating doses of weekly paclitaxel (Taxol) in combination with a fixed systemic administration of 5-fluorouracil (5-FU) in patients with advanced or metastatic gastric cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0368-2811
pubmed:author	pubmed-author:ArakiKyoujiroK, pubmed-author:HirabayashiNaokiN, pubmed-author:KataokaMasatoM, pubmed-author:KobayashiMichiyaM, pubmed-author:KojimaHiroshiH, pubmed-author:KondoKenK, pubmed-author:MatsuiTakanoriT, pubmed-author:MiyashitaYumiY, pubmed-author:NakaoAkimasaA, pubmed-author:NakazatoHiroakiH, pubmed-author:SakamotoJunichiJ, pubmed-author:TakiyamaWataruW
pubmed:issnType	Print
pubmed:volume	35
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	332-7
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15961435-Adult, pubmed-meshheading:15961435-Aged, pubmed-meshheading:15961435-Alopecia, pubmed-meshheading:15961435-Anemia, pubmed-meshheading:15961435-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15961435-Dose-Response Relationship, Drug, pubmed-meshheading:15961435-Drug Administration Schedule, pubmed-meshheading:15961435-Feasibility Studies, pubmed-meshheading:15961435-Female, pubmed-meshheading:15961435-Fluorouracil, pubmed-meshheading:15961435-Humans, pubmed-meshheading:15961435-Male, pubmed-meshheading:15961435-Maximum Tolerated Dose, pubmed-meshheading:15961435-Middle Aged, pubmed-meshheading:15961435-Neoplasm Recurrence, Local, pubmed-meshheading:15961435-Neutropenia, pubmed-meshheading:15961435-Paclitaxel, pubmed-meshheading:15961435-Stomach Neoplasms, pubmed-meshheading:15961435-Survival Rate
pubmed:year	2005
pubmed:articleTitle	Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
pubmed:affiliation	Department of Surgery, Nagoya National Hospital, 1-1, San-nomaru 4-chome, Naka-ku, Nagoya 460-0001, Japan. kkondnnh@ce.mbn.or.jp
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I